4797-10-8

Basic information

• Product Name: Phosphoramidic dichloride, [(phenylamino)carbonyl]-
• CAS NO: 4797-10-8
• Molecular Formula: C7H7Cl2N2O2P
• Molecular Weight: 253.025
• Mol File: 4797-10-8.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: Phosphoramidic dichloride, [(phenylamino)carbonyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Phosphoramidic dichloride, [(phenylamino)carbonyl]-(4797-10-8)
• EPA Substance Registry System: Phosphoramidic dichloride, [(phenylamino)carbonyl]-(4797-10-8)

Safety Data

• Hazardous Substances Data: 4797-10-8(Hazardous Substances Data)

Upstream product

• 870-30-4 isocyanatophosphonic dichloride 
• 62-53-3 aniline 

Downstream Products

• 98960-75-9 phenylcarbamoyl-amidophosphoric acid dimethyl ester 
• 1356035-60-3 5,5-dimethyl-2-(N-phenylureido)-1,3,2-dioxaphosphorinane-2-oxide 
• 1356035-59-0 2-(N-phenylureido)-1,3,2-oxazaphosphorinane-2-oxide 
• 1394907-53-9 benzylammonium (3-phenylureido)(benzylamino)phosphinate 
• 1394907-47-1 benzylmethylammonium (3-phenylureido)(benzylmethylamino)phosphinate 
• 1285490-92-7 5,5-dimethyl-2-(3-phenylureido)-1,3,2-diazaphosphorinane 
• 129416-36-0 C₁₉H₃₃N₄O₈P₃ 
• 33202-91-4 (N'-Phenyl-ureido)-phosphorsaeurediethylester 

Relevant articles and documents

Synthesis, crystal structure, biological evaluation, electronic aspects of hydrogen bonds, and QSAR studies of some new N-(substituted phenylurea) diazaphosphore derivatives as anticancer agents

A new series of 2-[N-(R-phenylureido)]-1,3,2-diazaphosphore-2-oxide derivatives (R = CH3, F, NO2, CN) were synthesized and characterized by 31P, 1H, 13C NMR and FT-IR spectral techniques. All the compounds were evaluated for their antibacterial activity against some Gram-positive, Gram-negative strains of bacteria, as well as for their cytotoxic effects on MCF-7, MDA-MB-231, PC-3, HeLa, and K562 human cell lines. In vitro activity results exhibited an important role for six-membered diaza ring in both assays as well as high effect of meta-methyl and ortho-fluoro substitutes on the aromatic ring against the studied human cell lines and B. subtilis bacteria, respectively. To understand the correlation between the anticancer activity and physicochemical properties of the synthesized compounds, the QSAR studies were carried out. Further, the crystal structure of compound 15 was investigated and revealed that the title derivative is composed of two symmetrically independent molecules in the solid state with anti configuration the C=O versus P=O. NBO and AIM analyses were performed to investigate electronic aspects of hydrogen bonding of the crystal cluster, which play an extremely important role in biochemical systems.

Synthesis and antimicrobial activity of 1-[(substituted carbamoyl)amino]-1H,3H-1λ5-[1,3,2]oxazaphospholo[3,4-a] benzimidazol-1-ones

1-[(Substituted carbamoyl)amino]-1H,3H-1λ5-[1,3,2]oxazaphospholo[3, 4-a]benzimidazol-1-ones were synthesized by reacting benzimidazole 2-methanol (4) with different chlorides of carbamidophosphoric acids (3) in the presence of triethylamine at 40-45°C. Th

Synthesis of N-(Substituted)-N′-[5,5′-bis(bromomethyl)-2-oxido- 1,3,2-dioxaphosphorinane-2yl] ureas

Synthesis of N-(Substituted)-N′-[5,5′bis(bromomethyl)-2-oxido- 1,3,2-dioxaphosphorinane-2yl] ureas has been accomplished by condensation of equimolar quantities of chlorides of various carbamidophosphoric acids 3 with 2,2′-bis(bromomethyl)l,3-propanediol